Literature DB >> 15151168

Stimulation of lipid peroxidation and impairment of glutathione-dependent defense system in Wistar rats treated with cryptopine, a rare non-narcotic opium alkaloid.

Ritu Aneja1, Anju Katyal, Ramesh Chandra.   

Abstract

The present study was designed to evaluate the effect of repeated oral administration of cryptopine at differential dosing regimens (50, 100, 150, 200 mg/kg bwt) in vivo on lipid peroxide measures, glutathione levels (GSH) and activity of glutathione S-transferase (GST) and glutathione reductase (GR) in the liver, spleen, kidney and lung of Male Wistar rats after a 5 day treatment period. In all the tissues examined, we observed an increase in lipid peroxidation and a decline in glutathione content and activity of glutathione S-transferase and glutathione reductase in a dose-dependent manner. The decrease in GSH content did not definitively correlate with a concomitant increase of lipid peroxidation in all the tissues. Our results ensemble that the enhancement of lipid peroxidation in the tissues investigated is a consequence of depletion of glutathione to certain critical levels and impairment of the glutathione-dependent enzyme systems viz. GST and GR. Our study potentiates that decreased levels of GSH may lead to lipid peroxidation, one of the key events in cellular damage. The inhibition of GST also suggests that the detoxification of the alkaloid could be suppressed following acute exposures. Conclusively, it appears that cryptopine in vivo disturbs the cellular defense system, so that it tips in the direction of autoxidative lipid peroxidation, producing cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151168     DOI: 10.1007/BF03190571

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  27 in total

1.  Chemicals, drugs, and lipid peroxidation.

Authors:  G L Plaa; H Witschi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

2.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

Authors:  D J Jollow; J R Mitchell; N Zampaglione; J R Gillette
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

3.  The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.

Authors:  G Minotti; S D Aust
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

4.  Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice.

Authors:  M Athar; W A Khan; H Mukhtar
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

5.  Mass spectral studies on aryl-substituted N-carbamoyl/N-thiocarbamoyl narcotine and related compounds.

Authors:  Shefali Aggarwal; Narendra N Ghosh; Ritu Aneja; Harish Joshi; Ramesh Chandra
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

6.  Oral cocaine produces dose-related hepatotoxicity in male mice.

Authors:  R Labib; R Turkall; M S Abdel-Rahman
Journal:  Toxicol Lett       Date:  2001-12-15       Impact factor: 4.372

7.  Morphine metabolism revisited: I. Metabolic activation of morphine to a reactive species in rats.

Authors:  M A Correia; J S Wong; E Soliven
Journal:  Chem Biol Interact       Date:  1984-05       Impact factor: 5.192

8.  Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer.

Authors:  J Mohandas; J J Marshall; G G Duggin; J S Horvath; D J Tiller
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

9.  4-Hydroxyalk-2-enals are substrates for glutathione transferase.

Authors:  P Alin; U H Danielson; B Mannervik
Journal:  FEBS Lett       Date:  1985-01-07       Impact factor: 4.124

10.  Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo.

Authors:  M Younes; C P Siegers
Journal:  Chem Biol Interact       Date:  1981-03-15       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.